Oncoplastic breast‐conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single‐center experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oncoplastic breast‐conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: A single‐center experience

Published:2020-12 Issue:12 Volume:26 Page:2391-2394
ISSN:1075-122X
Container-title:The Breast Journal
language:en
Short-container-title:Breast J

Author:

Crown Angelena¹²,Carlson Elizabeth³,Rocha Flavio G.³,Grumley Janie W.⁴

Affiliation:

1. Breast Service Department of Surgery Memorial Sloan Kettering Cancer Center New York NY USA

2. Breast Surgery True Family Women’s Cancer Center Seattle WA USA

3. Department of General Thoracic and Vascular Surgery Virginia Mason Medical Center Seattle WA USA

4. Margie Peterson Breast Center, Saint John's Health Center John Wayne Cancer Institute Santa Monica CA USA

Publisher

Hindawi Limited

Subject

Oncology,Surgery,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tbj.14093

Reference20 articles.

1. Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast

2. RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation

3. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial

4. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncoplastic Breast Surgery versus Conservative Mastectomy in the Management of Large Ductal Carcinoma In Situ (DCIS): Surgical, Oncological, and Patient-Reported Outcomes;Cancers;2022-11-16

2. The Selection of Treatment Modality for Breast Ductal Carcinoma In Situ: Experience From a Single Institution;Cancer Control;2021-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3